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Appraisal Critically Appraised Papers
Summary of: McDermott MM, Ades P, Guralnik JM (2009) 
Treadmill exercise and resistance training in patients with 
peripheral arterial disease with and without intermittent 
claudication: a randomized controlled trial. JAMA 301: 
165–174. [Prepared by Mark Elkins, CAP Co-ordinator.]
Question: Do treadmill training and resistance training 
improve the functional performance of patients with 
peripheral arterial disease (PAD)? Design: Randomised, 
controlled trial with blinded outcome assessment and 
stratification for symptoms of intermittent claudication 
(IC). Setting: Tertiary hospital in the USA. Participants: 
Participants with an ankle brachial index of 0.95 or less 
were recruited from vascular clinics and the community. 
Key exclusion criteria were critical limb ischaemia, foot 
ulcers, amputation, inability to attend or perform the 
interventions, and usual exercise comparable to the study 
regimens. Randomisation of 156 participants allotted 
51 to treadmill training, 52 to resistance training and 53 
to a control group. Interventions: The treadmill group 
performed supervised treadmill exercise 3 times per week 
for 6 months. Participants aimed to increase to 40 minutes 
by week 8, after which the speed or grade of the treadmill 
was progressed. Participants with IC were encouraged to 
exercise to near maximal leg symptoms. Asymptomatic 
participants exercised at a perceived exertion of 12 to 14 
on the Borg scale. The resistance group also performed 
supervised exercise 3 times per week for 6 months, 
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Synopsis
including 3 sets of 8 repetitions of resisted lower limb 
exercises. External resistance was maintained above 50% 
of 1 repetition maximum and perceived exertion at 12 to 14. 
The control group attended 11 sessions that were designed to 
provide contact with a health professional but not to change 
behaviour. Outcome measures: The primary outcomes 
were the change in the six-minute walk test (6MWT) and 
the short physical performance battery (SPPB) at 6 months. 
The SPPB assesses walking speed, balance, and sit-to-stand 
performance. Secondary outcome measures were treadmill 
endurance, lower limb strength, endothelial function 
measured non-invasively at the brachial artery, habitual 
physical activity measured over 7 days via an accelerometer, 
a walking impairment questionnaire (WIQ), and the SF-36 
quality of life questionnaire. Results: Compared to control, 
treadmill training significantly improved 6MW distance 
(by 36 m, 95% CI 15 to 57), total treadmill time (by 3.4 
min, 95% CI 2 to 4.8), pain-free treadmill time (by 1.6 min, 
95% CI 0.3 to 2.9), endothelial function, and the Distance 
domain of the WIQ. Compared to control, resistance 
training significantly improved total treadmill time (by 1.9 
min, 95% CI 0.5 to 3.3), knee extension strength (by 80 N, 
95% CI 37 to 124), and the Distance and Stair Climbing 
domains of the WIQ. Both regimens produced significant, 
7.5-point improvements in the Physical Functioning domain 
of the SF-36. Conclusion: Treadmill and resistance training 
have different benefits for people with peripheral arterial 
disease, but both improve quality of life.
Commentary
Previous studies of exercise for PAD have focused on 
patients with IC. In this study, patients without IC were 
also included and randomisation was stratified to ensure 
an even proportion was allocated to each treatment group. 
This strongly suggests that one premise of this study was 
to compare the effect of training on PAD patients with IC 
versus those without IC. The authors report only that these 
groups had ‘reasonably similar’ outcomes, stating that the 
trial was underpowered for this comparison to be made 
statistically. This may be because fewer than 20% of the 
participants had IC. Nevertheless, the high proportion of 
participants without IC provides welcome data about this 
under-investigated group.
Follow-up for the primary analysis was excellent at 92%. 
Some secondary outcomes had substantially lower follow-
up, ranging from 56% to 88%. Although this creates a 
source of error in the results, sensitivity analyses suggest 
that the missing data were not grossly atypical.
Specificity of training was clearly evident. Treadmill training 
significantly improved walk-based outcomes, whereas the 
effects of resistance training were non-significant or lesser. 
Conversely, only resistance training significantly improved 
strength-based outcomes. Despite these differences, the size 
of the effect on quality of life related to physical function 
was the same for the two regimens.
Clinically worthwhile improvements in six-minute walk 
distance have not been established in patients with PAD, 
unlike chronic obstructive pulmonary disease (COPD). 
The improvement in the treadmill training group of this 
cohort (20 m), while statistically significant, is less than the 
improvement considered clinically worthwhile in moderate 
to severe COPD patients (35 m) (Puhan et al 2008). As a 
result, it is difficult to state that the improvement in six-
minute walk distance was clinically significant in PAD 
patients.
The results of this study suggest that clinicians can train 
patients with PAD and physical limitation, regardless of the 
presence or absence of symptoms of IC. Furthermore, due to 
specificity of training, clinicians can prescribe the modality 
of exercise that more closely targets the specific problems 
of the individual patient, rather than a ‘one modality fits all’ 
approach.
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